Patents by Inventor Susana Nieto-Bergman

Susana Nieto-Bergman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EEF2K as modifiers of the PTEN/AKT pathway and methods of use
    Patent number: 8679763
    Abstract: Human EEF2K genes are identified as modulators of the PTEN/AKT pathway and thus are therapeutic targets for disorders associated with defective PTEN/AKT function. Methods for identifying modulators of PTEN/AKT comprising screening for agents that modulate the activity of EEF2K are provided.
    Type: Grant
    Filed: March 10, 2006
    Date of Patent: March 25, 2014
    Assignee: Exelixis, Inc.
    Inventors: Arthur Brace, Robert A. Blake, Lori S. Friedman, Lynn Margaret Bjerke, Kevin M. Ward, Susana Nieto-Bergman
  • EYA2S As Modifiers of the PTEN/AKT Pathway and Methods of Use
    Publication number: 20110135629
    Abstract: Human MPTENAKT genes are identified as modulators of the PTEN/AKT pathway, and thus are therapeutic targets for disorders associated with defective PTEN/AKT function. Methods for identifying modulators of PTEN/AKT, comprising screening for agents that modulate the activity of MPTENAKT are provided.
    Type: Application
    Filed: June 20, 2006
    Publication date: June 9, 2011
    Applicant: EXELIXIS, INC.
    Inventors: Arthur Brace, Margaret Lynn Bjerke, Susana Nieto-Bergman, Lori S. Friedman, Kevin Ward, Robert A. Blake
  • GALK1S AS MODIFIERS OF THE PTEN/AKT PATHWAY AND METHODS OF USE
    Publication number: 20100183583
    Abstract: Human GALK1 genes are identified as modulators of the PTEN/AKT pathway, and thus are therapeutic targets for disorders associated with defective PTEN/AKT function. Methods for identifying modulators of PTEN/AKT, comprising screening for agents that modulate the activity of GALK1 are provided.
    Type: Application
    Filed: June 20, 2006
    Publication date: July 22, 2010
    Applicant: EXELIXIS, INC.
    Inventors: Arthur Brace, Margaret Lynn Bjerke, Susana Nieto-Bergman, Lori S. Friedman, Kevin Ward, Robert A. Blake
  • CDC6S AS MODIFIERS OF THE PTEN/AKT PATHWAY AND METHODS OF USE
    Publication number: 20100122354
    Abstract: Human CDC6 genes are identified as modulators of the PTEN/AKT pathway, and thus are therapeutic targets for disorders associated with defective PTEN/AKT function. Methods for identifying modulators of PTEN/AKT, comprising screening for agents that modulate the activity of CDC6 are provided.
    Type: Application
    Filed: June 20, 2006
    Publication date: May 13, 2010
    Applicant: EXELIXIS, INC.
    Inventors: Arthur Brace, Margaret Lynn Bjerke, Susana Nieto-Bergman, Lori S. Friedman, Kevin Ward, Robert A. Blake
  • Eef2k as Modifiers of the Pten/Akt Pathway and Methods of Use
    Publication number: 20080193438
    Abstract: Human EEF2K genes are identified as modulators of the PTEN/AKT pathway and thus are therapeutic targets for disorders associated with defective PTEN/AKT function. Methods for identifying modulators of PTEN/AKT comprising screening for agents that modulate the activity of EEF2K are provided.
    Type: Application
    Filed: March 10, 2006
    Publication date: August 14, 2008
    Applicant: EXELIXIS INC.
    Inventors: Arthur Brace, Robert A. Blake, Lori S. Friedman, Lynn Margaret Bjerke, Kevin M. Ward, Susana Nieto-Bergman